Suchergebnisse - "Liptrott, Neill J"

PubPharm (63)

1

Age-differential CD13 and interferon expression in airway epithelia affect SARS-CoV-2 infection - Effects of vitamin D

enthalten in: Mucosal immunology | 2023

von Sposito, F. | Pennington, S. | David, C. | +7

2

Umbilical cord mesenchymal stromal cell-derived extracellular vesicles lack the potency to immunomodulate human monocyte-derived macrophages in vitro

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von da Silva, T. | Rendra, E. | David, C. | +5

3

Application of KU812 cells for assessing complement activation related effects by nano(bio)materials

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von David, C. | de la Fonteyne-Blankestijn, L. | Vermeulen, J. | +3

4

Preclinical Evaluation of Long-Acting Emtricitabine Semi-Solid Prodrug Nanoparticle Formulations

enthalten in: Pharmaceutics | 2023

von Curley, P. | Hobson, J. | Liptrott, N. | +14

5

Fate of intravenously administered umbilical cord mesenchymal stromal cells and interactions with the host's immune system

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Amadeo, F. | Hanson, V. | Liptrott, N. | +3

6

Intravenous Administration of Human Umbilical Cord Mesenchymal Stromal Cells Leads to an Inflammatory Response in the Lung

enthalten in: Stem cells international | 2023

von Hernandez Pichardo, A. | Wilm, B. | Liptrott, N. | +1

7

Umbilical cord mesenchymal stromal cell-derived extracellular vesicles lack the potency to immunomodulate human monocyte-derived macrophages in vitro

enthalten in: Biomedicine & pharmacotherapy | November 2023

von Borges da Silva, T. | Rendra, E. | David, C. | +5

8

Exposure of the Basophilic Cell Line KU812 to Liposomes Reveals Activation Profiles Associated with Potential Anaphylactic Responses Linked to Physico-Chemical Characteristics

enthalten in: Pharmaceutics | 2022

von Plant-Hately, A. | Eryilmaz, B. | David, C. | +4

9

Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis

enthalten in: bioRxiv.org | 2022

von Rajoli, R. | Pertinez, H. | Arshad, U. | +20

10

Prioritisation of potential anti-SARS-CoV-2 drug repurposing opportunities based on ability to achieve adequate plasma and target site concentrations derived from their established human pharmacokinetics

enthalten in: bioRxiv.org | 2022

von Arshad, U. | Pertinez, H. | Box, H. | +18

1
2
3
4
5
6
7
Nächster »
[7]